GLP-1 RA’s - Treating Obesity, the Potential, the Cost, and Coverage

The Moving to Value Alliance (MTVA) team talks with Sloan Saunders of IntelliHealth about the obesity crisis and the new class of prescription drugs, GLP-1s (Glucagon‐Like Peptide‐1 Receptor Agonists). This episode features: Steve Schutzer, MD, MTVA Founding Board Member & Co-Founder, Upswing Health Jeffrey Hogan, MTVA Founding Board Member & President, Upside Health Advisors John Rodis, MD, President, MTVA and Founder and President, Arista Health, LLC Sloan Saunders, CEO and Co-founder, IntelliHealth All episodes of MTVA Unscripted can be found ⁠here⁠.